NEW YORK (GenomeWeb) – RUCDR Infinite Biologics, a unit of the Rutgers Human Genetics Institute of New Jersey, has received a $19 million contract from the National Institute on Drug Abuse to expand the service offerings it provides through the NIDA Center for Genetic Studies, the Rutgers Office of Research and Economic Development said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: map of human protein interactions, mutant phenotype variability in organisms of the same species from different genetic backgrounds, and more.

Critics call the Fred Hutchinson Cancer Research Center's Gary Gilliland's prediction of cancer cures within 10 years "out of touch with reality" and "irresponsible."

Ivan Oransky discusses the need for reproducibility research at The Conversation.

The San Diego Union-Tribune posts videos from Biocom's Speaker Series with Illumina's Jay Flatley, who discusses Roche's failed hostile takeover bid.